Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV, Combination Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00046033
What this trial is testing

Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 118
Testing effectiveness (Phase 2)Study completedNCT00000803
What this trial is testing

A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 471
Testing effectiveness (Phase 2)Study completedNCT00001045
What this trial is testing

Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Post-approval studies (Phase 4)Ended earlyNCT00632970
What this trial is testing

Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals

Who this might be right for
HIV Infections
George Washington University 6
Large-scale testing (Phase 3)Ended earlyNCT00028067
What this trial is testing

A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor

Who this might be right for
HIV Infections
Bristol-Myers Squibb 500
Testing effectiveness (Phase 2)Study completedNCT00551330
What this trial is testing

Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED)

Who this might be right for
HIV InfectionsAcquired Immunodeficiency Syndrome
Merck Sharp & Dohme LLC 111
Testing effectiveness (Phase 2)Study completedNCT01878799
What this trial is testing

Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV

Who this might be right for
Hepatitis CHIV
National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Study completedNCT00000711
What this trial is testing

Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC

Who this might be right for
HIV InfectionsCytopenias
National Institute of Allergy and Infectious Diseases (NIAID) 60
Large-scale testing (Phase 3)Study completedNCT00002334
What this trial is testing

Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment

Who this might be right for
HIV Infections
Hoffmann-La Roche 3,000
Large-scale testing (Phase 3)Study completedNCT01499199
What this trial is testing

The Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 13
Large-scale testing (Phase 3)Study completedNCT00098293
What this trial is testing

Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine

Who this might be right for
HIV-1
ViiV Healthcare 916
Post-approval studies (Phase 4)Study completedNCT00752037
What this trial is testing

Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients

Who this might be right for
HIV Infections
Saint Michael's Medical Center 30
Post-approval studies (Phase 4)Study completedNCT01599364
What this trial is testing

Atazanavir/r + Lamivudine Dual Therapy

Who this might be right for
Human Immunodeficiency Virus
Catholic University of the Sacred Heart 266
Not applicableStudy completedNCT05413811
What this trial is testing

Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV

Who this might be right for
Cervical CancerCIN2CIN3+2 more
UNC Lineberger Comprehensive Cancer Center 180
Large-scale testing (Phase 3)Study completedNCT00002245
What this trial is testing

The Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome
Not applicableStudy completedNCT01524900
What this trial is testing

Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice

Who this might be right for
HIV Infections
Boehringer Ingelheim 398
Large-scale testing (Phase 3)Study completedNCT02284035
What this trial is testing

Safety & Efficacy of Dual Therapy With Raltegravir/Lamivudine

Who this might be right for
AIDS
Juan A. Arnaiz 75
Testing effectiveness (Phase 2)Study completedNCT00002184
What this trial is testing

A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient

Who this might be right for
HIV Infections
Gilead Sciences 120
Early research (Phase 1)Study completedNCT05261191
What this trial is testing

MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy

Who this might be right for
Human Immunodeficiency Virus I InfectionImmunodeficiency Virus Type 1, HumanHuman Immunodeficiency Virus Type 1
MacroGenics 17
Testing effectiveness (Phase 2)Ended earlyNCT00002420
What this trial is testing

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

Who this might be right for
HIV Infections
Bristol-Myers Squibb 25
Next Page